NDC 0832-0044-89 - amlodipine besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0832-0044
- Requested NDC
- 0832-0044-89
- Package NDCs from labels
- 0832-0044-09, 0832-0044-10, 0832-0044-89, 0832-0044-01
- Manufacturer
- Upsher-Smith Laboratories, LLC
- Effective date
- 2020-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| amlodipine besylate - Upsher-Smith Laboratories, LLC | Upsher-Smith Laboratories, LLC | 2020-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| amlodipine besylate | ACTIVE INGREDIENT | 864V2Q084H | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| amlodipine | ACTIVE MOIETY | 1J444QC288 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| calcium phosphate, dibasic, dihydrate | INACTIVE INGREDIENT | O7TSZ97GEP | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 | |
| sodium starch glycolate type A potato | INACTIVE INGREDIENT | 5856J3G2A2 | AMLODIPINE BESYLATE TABLET [UPSHER-SMITH LABORATORIES, INC.] | 11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Azor | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | Cosette Pharmaceuticals, Inc. | c5535406-b63b-49aa-88b9-169aaf0ed08e | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Tribenzor | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Cosette Pharmaceuticals, Inc. | 2f56d0bc-236b-41a0-9fc0-21cdfea8d890 | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | ced6d26e-8c54-4808-88b6-446344f4acd0 | 2023-06-01 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 186b6149-9610-4380-9bf2-941646069276 | 2023-05-04 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | BluePoint Laboratories | df8e23c8-6c8f-4293-8a37-5ad3d48dba94 | 2023-05-03 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE 5 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | b597d1e1-aba1-4272-bed7-4c95e8150d58 | 2023-04-19 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine besylate | AMLODIPINE BESYLATE | Exelan Pharmaceuticals, Inc. | efd9eda5-f497-45a3-ae13-dee729add999 | 2023-03-23 | Warnings, Adverse reactions | 864V2Q084H |
| Norvasc | AMLODIPINE BESYLATE | Viatris Specialty LLC | 7367289c-b0b0-466a-83e2-558e2985c29f | 2023-02-15 | Warnings, Adverse reactions | 864V2Q084H |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Alembic Pharmaceuticals Limited | 15b438b4-4874-43f4-a50a-4e6f3e5530ac | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Valsartan | AMLODIPINE AND VALSARTAN | Alembic Pharmaceuticals Limited | a9c442dc-749e-4de0-bca3-1044eb78da72 | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine besylate and Olmesartran medoxomil | AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL | Alembic Pharmaceuticals Limited | cb2df7f7-fee8-42ba-8936-0788c4fcc0cb | 2023-01-23 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Dr.Reddy's Laboratories Limited | f12f18bb-7ddb-e7dc-4edd-32f4ac212bca | 2022-12-23 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Dr.Reddy's Laboratories Limited | ca014f06-982c-6fe1-9948-a3701dd35d34 | 2022-12-23 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Unichem Pharmaceuticals (USA), Inc. | a516b336-8f60-4b86-8921-c7d6c07629f2 | 2022-12-05 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | Proficient Rx LP | 29a0d87e-6afb-4766-9045-1963c5b0d183 | 2022-11-01 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| amlodipine besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | f3482709-c5c3-4bd0-8067-ad57f31bb525 | 2022-10-18 | Warnings, Adverse reactions | 864V2Q084H |
| 541a80ac-c064-4d44-8512-740d26cbb732 | dd6f9f66-148a-4ecc-9fb9-a58e2b6fbc79 | 2022-09-28 | Warnings, Adverse reactions | dd6f9f66-148a-4ecc-9fb9-a58e2b6fbc79 | ||
| AMLODIPINE AND VALSARTAN | AMLODIPINE AND VALSARTAN | Lupin Pharmaceuticals,Inc. | e05dd72c-7475-422e-bf8e-73148929450e | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | 445d1274-7249-476b-ad90-ff93aee56f6d | 2022-06-01 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Proficient Rx LP | 5f3ac64c-6e33-40c1-9b8e-dc0c8dd7e8d6 | 2022-04-01 | Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.